65IB drugs, pharmacueticals and hematology related products

Ended Awarded Last action

Contract number
V797D30071
Awardee
Awarding agency
Task orders
2

Award facts

Last date to order 100% complete
IDV ceiling
$691,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Krystexxa medication 36C26219N1285 Veterans Integrated Service Network 22 (VHA) $31,610
Krystexxa 36C26119F0497 Veterans Integrated Service Network 21 (VHA) $31,610

IDV awards

IDV Agency Ceiling Awarded
36E79719A0018 BPA for krystexxa National Acquisition Center (VA) $18,000,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00042 · Temp EXT $0
Supplemental Agreement for work within scope P00041 · TMP EXT to 7-31-2019 $0
Supplemental Agreement for work within scope P00040 · Updated specialty distribution forms $0
Supplemental Agreement for work within scope P00039 · Specialty distribution for krystexxa (NDC 75987-0080-10) $0
Other Administrative Action P00037 · Agent authorization update $0
Supplemental Agreement for work within scope P00038 · Temp contract extention $0
Supplemental Agreement for work within scope P00036 · 42-2A and 42-2B product deletion $0
Supplemental Agreement for work within scope P00035 · Temporary contract extension $0
Supplemental Agreement for work within scope P00034 · 2019 public law pricing update $0
Supplemental Agreement for work within scope P00033 · 42-2A product deletion $0
Other Administrative Action P00032 · Point of contact change $0
Supplemental Agreement for work within scope P00031 · 65IB - temporary contract extension $0
Supplemental Agreement for work within scope P00030 · 42-2A NDC change $0
Supplemental Agreement for work within scope P00029 · NDC change $0
Supplemental Agreement for work within scope P00028 · 42-2A product deletion $0
Supplemental Agreement for work within scope P00027 · Short term contract extension $0
Supplemental Agreement for work within scope P00026 · 42-2A NDC change $0
Supplemental Agreement for work within scope P00025 · PL update. $0
Supplemental Agreement for work within scope P00024 · NDC change $0
Supplemental Agreement for work within scope P00023 · 42-2A - product addition $0
Supplemental Agreement for work within scope P00021 · Short term extension $0
Supplemental Agreement for work within scope P00022 · NDC change (krystexxa) $0
Supplemental Agreement for work within scope P00019 · Specialty distributor VA ordering information $0
Supplemental Agreement for work within scope P00020 · NDC change $0
Supplemental Agreement for work within scope P00018 · 42-2A product addition $0
Supplemental Agreement for work within scope P00017 · 2017 public pricing update $0
Supplemental Agreement for work within scope P00016 · 65IB drugs, pharmaceuticals and hematology related products /signatory authority update and address change $0
Supplemental Agreement for work within scope P00014 · 65IB drugs, pharmaceuticals and hematology related products / product addition krystexxa and migergot. $0
Supplemental Agreement for work within scope P00015 · 65IB drugs, pharmaceuticals and hematology related products /signatory authority update and address change $0
Supplemental Agreement for work within scope P00013 · 65IB drugs, pharmaceuticals and hematology related products / NDC change $0
Supplemental Agreement for work within scope P00012 · 65IB drugs, pharmaceuticals and hematology related products / 2016 PL pricing update $0
Supplemental Agreement for work within scope P00010 · 65IB drugs, pharmaceuticals and hematology related products / admin change $0
Supplemental Agreement for work within scope P00009 · 65IB drugs, pharmaceuticals and hematology related products / product additions ravicti and buphenyl. $0
Supplemental Agreement for work within scope P00008 · Admin change $0
Supplemental Agreement for work within scope P00007 · 65IB drugs, pharmacueticals and hematology related products - product additions, pennsaid $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 · 65IB drugs, pharmacueticals and hematology related products - 2014 public law updates $0
Other Administrative Action P00002 $0
Original award $0
Show all 40

Quick answers

Who was awarded contract V797D30071?

V797D30071 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on January 1, 2013.

How much is contract V797D30071 worth?

V797D30071's own ceiling is $691,000.

How many orders have been placed under contract V797D30071?

2 orders have been placed under V797D30071, the latest on August 7, 2019.

Who can order from contract V797D30071?

V797D30071 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract V797D30071 part of a contract vehicle?

Yes. V797D30071 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract V797D30071 competed?

The extent of competition for V797D30071 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV